Day: November 14, 2025

Second quarter results highlight improved cost management capital structure enhancements DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 second quarter, which ended September 30, 2025. Commenting on the fiscal 2026 second quarter results, interim Chief Executive Officer James Silk said: “The second quarter results demonstrate our disciplined approach to managing both our investment portfolio and operating expenses during a pivotal period for Beneficient. We reduced expenses, completed new primary capital transactions, generated additional liquidity through asset sales...

Total Revenue of $77.7 million, an increase of approximately 15% quarter-over-quarter Net Income of $1.3 million Record Adjusted EBITDA of $56.3 million, an increase of over 45% quarter-over-quarter Approximately 10% increase in quarterly production to a total of 23,029 Boe/d per day (52% oil / 72% liquids) Current production rate of approximately 27,000 net Boe/d per dayHOUSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company,” “Prairie,” “we,” “our,” or “us”) – an independent energy company engaged in the development and acquisition of oil, natural gas, and natural gas liquids (“NGL”) resources in the Denver-Julesburg (DJ) Basin – today announced its financial and operational results through and subsequent to the quarter ended September 30, 2025. RECENT KEY HIGHLIGHTSRecord total production...

Company to host investor conference call and webcast on Monday, November 17th, at 9:00am EST PITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI), an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today reported financial and operating results for the quarter ended September 30, 2025, and provided a corporate update. Q3 2025 and Recent Highlights:Announced the initiation of a digital asset treasury strategy focused on ATH, the native utility token of the Aethir ecosystem, supported by two private placements pursuant to which the Company received aggregate cash gross proceeds of approximately $50.8 million and in-kind contributions of locked and unlocked ATH with an aggregate notional...

CALGARY, Alberta, Nov. 14, 2025 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (“Prairie Provident” or the “Company”) (TSX:PPR) announces its financial and operating results for the third quarter of 2025. The Company’s interim financial statements for the three and nine months ended September 30, 2025 and related Management’s Discussion and Analysis (“MD&A”) are available on our website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca. THIRD QUARTER 2025 FINANCIAL AND OPERATING HIGHLIGHTSProduction averaged 2,295 boe/d (57% liquids)1 for Q3 2025, which was 6% or 122 boe/d higher than Q3 2024, due to the increased Basal Quartz production. Q3 2025 operating expenses were $30.39 boe/d, an increase of 13% or $3.46 per boe/d from Q3 2024, principally due to higher spending with respect to chemicals,...

LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — XMax Inc. (“Xmax” or the “Company”) (NASDAQ: XWIN), today announced its unaudited financial results for the three months ended September 30, 2025. Operating Results for the Three Months ended September 30, 2025Net Sales grew by 273% to $9.76 million from $2.62 million in the same period of 2024. Gross profit was $0.98 million, compared to $1.18 million in the same period of 2024. Net loss was $1.13 million, compared to a net loss of $2.47 million in the same period of 2024.Operating Results for the Nine Months Ended September 30, 2025:Net Sales grew by 95% to $14.95 million from $7.68 million in the same period of 2024. Gross profit was $3.47 million, compared to $3.39 million in the same period of 2024. Net loss was $1.76 million, compared to a net loss...

MIRAMAR, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and diseases, today reported financial results and recent business highlights for its third quarter ended September 30, 2025. The Company anticipates dosing the first patient in a Phase 1 clinical study (NCT07049328) to evaluate HCW9302 in patients with an autoimmune disease in the fourth quarter of 2025. HCW9302 is the Company’s lead product candidate for its clinical program to develop treatments for autoimmune diseases and inflammatory conditions. HCW9302 is a subcutaneously injectable, first-in-kind interleukin 2 (“IL-2”) fusion molecule constructed...

HONG KONG, Nov. 14, 2025 (GLOBE NEWSWIRE) — Oriental Culture Holding LTD. (“OCG” or the “Company”) (NASDAQ: OCG), an online provider of collectibles and artwork e-commerce services, today announced its unaudited financial results for the six months ended June 30, 2025. First Half Year of 2025 Financial HighlightsTotal revenues were approximately $0.1 million for the six months ended June 30, 2025, compared with the total revenues of approximately $0.4 million for the six months ended June 30, 2024.Gross profit was approximately $0.1 million for the six months ended June 30, 2025, compared with approximately gross profit of $0.3 million for the six months ended June 30, 2024.Gross margin was 84.7% for the six months ended June 30, 2025, compared with a gross margin of 65.8% for the six months ended June 30, 2024.Loss from...

Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024 Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin Expanded to 81.7% in Q3 2025, a 1,302 BPS Increase Management to Host Third Quarter 2025 Results Conference Call Today, Friday, November 14, 2025 at 4:30 p.m. Eastern Time SEATTLE, Nov. 14, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Subsequent Key Financial & Operational HighlightsRevenue of $2.8 million for Q3 2025, representing an increase of 163% over Q3 2024. Gross profit of $2.3 million for Q3 2025, representing an increase of 213%...